Search Results - "Bonadiman, L"

Refine Results
  1. 1

    Prevalence of different comorbidities in COPD patients by gender and GOLD stage by Dal Negro, R W, Bonadiman, L, Turco, P

    Published in Multidisciplinary respiratory medicine (05-08-2015)
    “…Several comorbidities frequently affect COPD progression. Aim of the study was to assess the prevalence of main comorbidities by gender and disease severity in…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Prevalence of different comorbidities in COPD patients by gender and GOLD stage by Dal Negro, Roberto W., Bonadiman, L., Turco, P.

    Published in Multidisciplinary respiratory medicine (05-08-2015)
    “…Background: Several comorbidities frequently affect COPD progression. Aim of the study was to assess the prevalence of main comorbidities by gender and disease…”
    Get full text
    Journal Article
  4. 4

    Changes of clinical outcomes and health care resources in moderate and in severe COPD treated uniquely with tiotropium 18 mcg od for twenty-four months by Dal Negro, R.W, Bonadiman, L, Micheletto, C, Tognella, S, Turati, C, Turco, P

    Published in Pulmonary pharmacology & therapeutics (01-08-2011)
    “…Abstract Chronic obstructive pulmonary disease (COPD) is a complex and progressive respiratory disease characterized by incompletely reversible bronchial…”
    Get full text
    Journal Article
  5. 5

    Reconsidering patient empowerment in chronic illness: A critique of models of self-efficacy and bodily control by Aujoulat, Isabelle, Marcolongo, Renzo, Bonadiman, Leopoldo, Deccache, Alain

    Published in Social science & medicine (1982) (01-03-2008)
    “…Studies that focus on patient empowerment tend to address more specifically two issues of patients' experience of illness: managing regimens and relating to…”
    Get full text
    Journal Article
  6. 6

    Therapeutic education in urology: a fundamental resource for the sick and the health carers by Bassi, P F, Falabella, R, Bonadiman, L, Marcolongo, R

    Published in Urologia (01-07-2008)
    “…Therapeutic Education (TE) means to build a partnership between doctors and patients comparing knowledge and therapeutic procedures to manage the disease and…”
    Get full text
    Journal Article
  7. 7

    Re: Potential Use of Imatinib in Ewing’s Sarcoma: Evidence for In Vitro and In Vivo Activity by Tamborini, Elena, Bonadiman, Lorena, Albertini, Veronica, Pierotti, Marco A., Pilotti, Silvana

    “…Fig. 1. Expression of KIT protein and phosphorylated KIT protein in [Ewing]'s sarcoma specimens. Tumors that expressed both KIT and stem cell factor (SCF) mRNA…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update by Dal Negro, Roberto W, Bonadiman, Luca, Turco, Paola, Tognella, Silvia, Iannazzo, Sergio

    Published in ClinicoEconomics and outcomes research (01-01-2015)
    “…Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity and mortality worldwide, and its epidemiological, clinical, and…”
    Get full text
    Journal Article
  16. 16

    Detection of Overexpressed and Phosphorylated Wild-Type Kit Receptor in Surgical Specimens of Small Cell Lung Cancer by TAMBORINI, Elena, BONADIMAN, Lorena, NEGRI, Tiziana, GRECO, Angela, STAURENGO, Samantha, BIDOLI, Paolo, PASTORINO, Ugo, PIEROTTI, Marco A, PILOTTI, Silvana

    Published in Clinical cancer research (15-12-2004)
    “…Purpose: The combinations of various chemotherapeutic drugs currently used to treat advanced small cell lung cancer (SCLC) led to similarly poor survival…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Expression of Ligand-Activated KIT and Platelet-Derived Growth Factor Receptor β Tyrosine Kinase Receptors in Synovial Sarcoma by TAMBORINI, Elena, BONADIMAN, Lorena, GRECO, Angela, GRONCHI, Alessandro, RIVA, Carla, BERTULLI, Rossella, CASALI, Paolo G, PIEROTTI, Marco A, PILOTTI, Silvana

    Published in Clinical cancer research (01-02-2004)
    “…Purpose: The use of tyrosine kinase receptor inhibitors is increasingly becoming a valuable therapeutic alternative in tumors carrying activated tyrosine…”
    Get full text
    Journal Article
  19. 19

    Glutathione peroxidase, selenium, and prostaglandin synthesis in platelets by Doni, M G, Avventi, G L, Bonadiman, L, Bonaccorso, G

    Published in The American journal of physiology (01-05-1981)
    “…Glutathione peroxidase (GSH-Px) contains 4 selenium atoms/molecule; its activity is increased by selenium dietary intake. The enzyme destroys H2O2 and organic…”
    Get full text
    Journal Article
  20. 20

    Mutation K448E in the external loop 5 of rat GABA transporter rGAT1 induces pH sensitivity and alters substrate interactions by Forlani, Greta, Bossi, Elena, Ghirardelli, Roberta, Giovannardi, Stefano, Binda, Francesca, Bonadiman, Lorena, Ielmini, Lorena, Peres, Antonio

    Published in The Journal of physiology (15-10-2001)
    “…The effect of the mutation K448E in the rat GABA transporter rGAT1 was studied using heterologous expression in Xenopus oocytes and voltage clamp. At neutral…”
    Get full text
    Journal Article